Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.

BACKGROUND The role of lycopene in prostate cancer prevention remains controversial. We examined the associations between dietary lycopene intake and prostate cancer, paying particular attention to the influence of prostate-specific antigen screening, and evaluated tissue biomarkers in prostate cancers in relation to lycopene intake. METHODS Among 49898 male health professionals, we obtained dietary information through questionnaires and ascertained total and lethal prostate cancer cases from 1986 through January 31, 2010. Cox regression was used to estimate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs). Tissue microarrays and immunohistochemistry were used to assess tumor biomarker expression in a subset of men. Two-sided χ(2) tests were used to calculate the P values. RESULTS Higher lycopene intake was inversely associated with total prostate cancer and more strongly with lethal prostate cancer (top vs bottom quintile: HR = 0.72; 95% CI = 0.56 to 0.94; P(trend) = .04). In a restricted population of screened participants, the inverse associations became markedly stronger (for lethal prostate cancer: HR = 0.47; 95% CI = 0.29 to 0.75; P trend = .009). Comparing different measures of dietary lycopene, early intake, but not recent intake, was inversely associated with prostate cancer. Higher lycopene intake was associated with biomarkers in the cancer indicative of less angiogenic potential. CONCLUSIONS Dietary intake of lycopene was associated with reduced risk of lethal prostate cancer and with a lesser degree of angiogenesis in the tumor. Because angiogenesis is a strong progression factor, an endpoint of lethal prostate cancer may be more relevant than an endpoint of indolent prostate cancer for lycopene in the era of highly prevalent prostate-specific antigen screening.

[1]  M. Loda,et al.  Protein Expression of PTEN, Insulin-Like Growth Factor I Receptor (IGF-IR), and Lethal Prostate Cancer: A Prospective Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[2]  C. Chuang,et al.  Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells. , 2013, The Journal of nutritional biochemistry.

[3]  Jennifer R. Rider,et al.  The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Chih-min Yang,et al.  Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. , 2012, Molecular nutrition & food research.

[5]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[6]  A. Cooper,et al.  Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings , 2011, British Journal of Nutrition.

[7]  D. Ilic,et al.  Lycopene for the prevention of prostate cancer. , 2011, The Cochrane database of systematic reviews.

[8]  E. Giovannucci Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial , 2011, Cancer Causes & Control.

[9]  Chih-min Yang,et al.  Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. , 2011, Molecular nutrition & food research.

[10]  I. Thompson,et al.  Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[11]  I. Thompson,et al.  American Journal of Epidemiology Original Contribution Diet, Supplement Use, and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial , 2022 .

[12]  J. Beilby,et al.  Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk , 2010, European Journal of Clinical Nutrition.

[13]  Stacey A. Kenfield,et al.  Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Nurmi,et al.  Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. , 2009, Annals of epidemiology.

[15]  M. Rubin,et al.  Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality , 2009, Cancer Epidemiology Biomarkers & Prevention.

[16]  Yan Liu,et al.  Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.

[17]  F. Berrino,et al.  Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. , 2007, The American journal of clinical nutrition.

[18]  E. Giovannucci Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk? , 2007, Journal of the National Cancer Institute.

[19]  P. Trumbo,et al.  The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. , 2007, Journal of the National Cancer Institute.

[20]  B. Saboury,et al.  The risk factors of prostate cancer: a multicentric case-control study in Iran. , 2007, Asian Pacific journal of cancer prevention : APJCP.

[21]  H. Nagaraja,et al.  Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects , 2007, British Journal of Nutrition.

[22]  Nilanjan Chatterjee,et al.  Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  Andy H. Lee,et al.  Tea and lycopene protect against prostate cancer. , 2007, Asia Pacific journal of clinical nutrition.

[24]  R. Hayes,et al.  A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  Andy H. Lee,et al.  Do dietary lycopene and other carotenoids protect against prostate cancer? , 2005, International journal of cancer.

[26]  S. Clinton,et al.  Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. , 2005, The Journal of nutrition.

[27]  C. la Vecchia,et al.  Retinol, carotenoids and the risk of prostate cancer: A case‐control study from Italy , 2004, International journal of cancer.

[28]  M. Etminan,et al.  The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  John W Erdman,et al.  Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.

[30]  J. Cerhan,et al.  Cancer Mortality among Iowa Farmers: Recent Results, Time Trends, and Lifestyle Factors (United States) , 1998, Cancer Causes & Control.

[31]  A. Alberg,et al.  Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. , 2003, American journal of epidemiology.

[32]  E. Giovannucci A Review of Epidemiologic Studies of Tomatoes, Lycopene, and Prostate Cancer , 2002, Experimental biology and medicine.

[33]  R. Hayes,et al.  Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. , 2002, American journal of epidemiology.

[34]  E. Rimm,et al.  A prospective study of tomato products, lycopene, and prostate cancer risk. , 2002, Journal of the National Cancer Institute.

[35]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[36]  A. Ronco,et al.  Foods, nutrients and prostate cancer: a case–control study in Uruguay , 1999, British Journal of Cancer.

[37]  G R Howe,et al.  Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. , 1999, Nutrition and cancer.

[38]  R. Goldbohm,et al.  Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. , 1998, Cancer Epidemiology, Biomarkers and Prevention.

[39]  I. Bairati,et al.  Dietary energy and nutrients in relation to preclinical prostate cancer. , 1997, Nutrition and cancer.

[40]  D. Bishop,et al.  A case-control study of diet and prostate cancer. , 1997, British Journal of Cancer.

[41]  G A Colditz,et al.  Intake of carotenoids and retinol in relation to risk of prostate cancer. , 1995, Journal of the National Cancer Institute.

[42]  Joanne M. Holden,et al.  Carotenoid content of thermally processed tomato-based food products , 1995 .

[43]  J M Holden,et al.  Carotenoid content of fruits and vegetables: an evaluation of analytic data. , 1993, Journal of the American Dietetic Association.

[44]  G. Beecher,et al.  The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. , 1993, Journal of the American Dietetic Association.

[45]  L. Kolonel,et al.  Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. , 1991, American journal of epidemiology.

[46]  W. L. Beeson,et al.  Cohort study of diet, lifestyle, and prostate cancer in adventist men , 1989, Cancer.

[47]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[48]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.